ACTA NEUROPHARMACOLOGICA››2021,Vol. 11››Issue (4): 38-.DOI:10.3969/j.issn.2095-1396.2021.04.008

Previous ArticlesNext Articles

Advances in Pharmacological Researches of Curcumin on Brain Ischemia-Reperfusion Injury

SUN YuLI PengYANG Peng-fei

  1. College of PharmacyXinxiang Medical UniversityHenan International Joint Laboratory of Cardiovascular Remodeling and Drug InterventionXinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug DevelopmentXinxiang453003China

  • Online:2021-08-26Published:2021-08-26

Abstract:

Stroke is the primary cause for permanent disability in adults worldwideand characterized by the obvious neurological deficit symptoms resulted from acute blood circulation disorder. Two pathological damage processes involved in strokeincluding primary brain injury caused by ischemia and ischemia-reperfusion injury caused by rapid blood flow recoveryand the latter one plays more important role in causing death and disability in stroke patients. Curcuminwhich is the main active component in the dried rhizome of Curcuma longa L.possesses a wide range of pharmacological activities. This review based on the pathological mechanism of cerebral ischemia-reperfusion injuryincluding mitochondrial dysfunctionoxidative stressneuroinflammationexcitatory amino acid toxicitycalcium overload and programmed death of neuronsdiscussed the pharmacological benefit of curcumin in alleviating cerebral ischemiareperfusion injuryand hopes to provide theoretical basis for the mechanism study and the development of curcumin.

Key words:turmeric,brain ischemia/reperfusion injury,pharmaceutical benefit

CLC Number:

Baidu
map